Neoantigen Vaccines Pass the Immunogenicity Test

被引：35

作者：

Linette, Gerald P. ^{[1
,2
]}

Carreno, Beatriz M. ^{[2
,3
]}

机构：

[1] Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Dept Hematol Oncol, Philadelphia, PA 19104 USA

[2] Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA

[3] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA

来源：

TRENDS IN MOLECULAR MEDICINE | 2017年 / 23卷 / 10期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1016/j.molmed.2017.08.007

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Neoantigens arising from tumor-specific genomic alterations constitute authentic non-self antigens and represent a new class of targets for cancer immunotherapy. Recent reports on various vaccine platforms targeting neoantigens suggest a basis for precision therapies customized to each patient's tumor mutational profile.

引用

页码：869 / 871

页数：3

共 50 条

[1] Immunogenicity comparison of neoantigen vaccines through different delivery platform
Jiang, H. -T.
Shen, H. -C.
Lee, I. -J. L.
Liao, Y. -S.
Wu, P. -Y.
Tao, M. -H.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1697 - 1698
[2] Immunogenicity comparison of neoantigen vaccines through different delivery platform
Wu, Pinyi
Jiang, Haitao
Shen, Hao-chun
Tao, Mi-Hua
JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
[3] Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Zhang, Rui
Yuan, Fengjiao
Shu, Yang
Tian, Yaomei
Zhou, Bailing
Yi, Linglu
Zhang, Xueyan
Ding, Zhenyu
Xu, Heng
Yang, Li
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (01) : 135 - 145
[4] Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Rui Zhang
Fengjiao Yuan
Yang Shu
Yaomei Tian
Bailing Zhou
Linglu Yi
Xueyan Zhang
Zhenyu Ding
Heng Xu
Li Yang
Cancer Immunology, Immunotherapy, 2020, 69 : 135 - 145
[5] Determinants of neoantigen immunogenicity
Delamarre, Lelia
CANCER RESEARCH, 2018, 78 (13)
[6] Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines
Qiu, Feng
Becker, Kyle W.
Knight, Frances C.
Baljon, Jessalyn J.
Sevimli, Sema
Shae, Daniel
Gilchuk, Pavlo
Joyce, Sebastian
Wilson, John T.
BIOMATERIALS, 2018, 182 : 82 - 91
[7] Neoantigen Vaccines in Cancer Prevention
Martel-Martel, Abel
Sinha, Krishna M.
Vilar, Eduardo
CANCER JOURNAL, 2025, 31 (02):
[8] Molecular mechanism of phosphopeptide neoantigen immunogenicity
Yury Patskovsky
Aswin Natarajan
Larysa Patskovska
Samantha Nyovanie
Bishnu Joshi
Benjamin Morin
Christine Brittsan
Olivia Huber
Samuel Gordon
Xavier Michelet
Florian Schmitzberger
Robert B. Stein
Mark A. Findeis
Andy Hurwitz
Marc Van Dijk
Eleni Chantzoura
Alvaro S. Yague
Daniel Pollack Smith
Jennifer S. Buell
Dennis Underwood
Michelle Krogsgaard
Nature Communications, 14
[9] Structure Based Prediction of Neoantigen Immunogenicity
Riley, Timothy P.
Keller, Grant L. J.
Smith, Angela R.
Davancaze, Lauren M.
Arbuiso, Alyssa G.
Devlin, Jason R.
Baker, Brian M.
FRONTIERS IN IMMUNOLOGY, 2019, 10
[10] Immunogenicity test of tetanus component in adsorbed vaccines by toxin binding inhibition test
Matos, DCS
Marcovistz, R
Cabello, PH
Georgini, RA
Sakauchi, D
da Silva, LL
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2002, 97 (06): : 909 - 913

← 1 2 3 4 5 →